Cantourage Group SE (XTER:HIGH) Research & Development: €0.00 Mil (TTM As of Jun. 2025)


XTER:HIGH Cantourage Group SE XTER:HIGH
22 GF Score
Price €6.26
! 4 Warning Signs
View Full Analysis

What is Cantourage Group SE Research & Development?

Cantourage Group SE XTER:HIGH +3.64% 22 Research & Development is €0.00 Mil as of Jun. 2025. GuruFocus rates XTER:HIGH with a GF Score™ of 22/100. The stock has 4 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Cantourage Group SE's Research & Development for the six months ended in Jun. 2025 was €0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Jun. 2025 was €0.00 Mil.

Cantourage Group SE  (XTER:HIGH) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Cantourage Group SE Research & Development Related Terms

Cantourage Group SE Research & Development Historical Data

* Premium members only.

The historical data trend for Cantourage Group SE's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cantourage Group SE Research & Development Chart

Cantourage Group SE Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
0.00 0.00 0.00 0.00 0.00

Cantourage Group SE Semi-Annual Data
Dec19 Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Jun25
Research & Development Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 0.00 0.00
XTER:HIGH
22GF Score
Cantourage Group SE XTER:HIGH
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cantourage Group SE Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Jun. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €0.00 Mil mean?
Cantourage Group SE (XTER:HIGH) has a Research & Development of €0.00 Mil as of Jun. 2025. Research and development expense is the total cost for research and development activities. View historical data on Cantourage Group SE and its competitors.
Is Cantourage Group SE's Research & Development too high?
Cantourage Group SE's current Research & Development is €0.00 Mil. Overall, Cantourage Group SE has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Cantourage Group SE's Research & Development compare to ZTS and UTHR?
Cantourage Group SE's Research & Development of €0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Drug Manufacturers company?
A good Research & Development depends on the Drug Manufacturers industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Cantourage Group SE and its competitors. Cantourage Group SE's current Research & Development is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cantourage Group SE stock overvalued right now?
Cantourage Group SE (XTER:HIGH) has a current Research & Development of €0.00 Mil. The current Research & Development is €0.00 Mil. Cantourage Group SE's overall GF Score™ is 22/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Cantourage Group SE (XTER:HIGH), the current Research & Development is €0.00 Mil as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cantourage Group SE Business Description

Address Feurigstrasse 54, Berlin, DEU, 10827
Cantourage Group SE is engaged in the manufacture and wholesale of medicinal preparations based on cannabis and the trade and distribution of other legally permissible cannabis products, medical devices, pharmaceuticals, and accessories. The group offers cannabis flowers, dronabinol, CBD, and extracts of various strains.
22GF Score

Get the complete analysis for XTER:HIGH

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€6.26
Price